Nakerakanti Sashidhar, Trojanowska Maria
Arthritis Center, Boston University School of Medicine, 72 East Concord St, Boston, MA 02118, USA.
Open Rheumatol J. 2012;6:156-62. doi: 10.2174/1874312901206010156. Epub 2012 Jun 15.
Recent advances in defining TGF-β signaling pathways have provided a new level of understanding of the role of this pleiotropic growth factor in the development of fibrosis. Here, we review selected topics related to the profibrotic role of TGF-β . We will discuss new insights into the mechanisms of ligand activation and the contribution of Erk1/2 MAPK, PI3K/FAK, and Endoglin/Smad1 signaling pathways to the process of fibrosis. There is growing evidence of the disease-specific alterations of the downstream components of the TGF-β signaling pathway that may be explored for the future therapeutic interventions.
在确定转化生长因子-β(TGF-β)信号通路方面的最新进展,为理解这种多效性生长因子在纤维化发展中的作用提供了新的层面。在此,我们综述与TGF-β促纤维化作用相关的特定主题。我们将讨论关于配体激活机制的新见解,以及细胞外信号调节激酶1/2(Erk1/2)丝裂原活化蛋白激酶(MAPK)、磷脂酰肌醇-3激酶(PI3K)/黏着斑激酶(FAK)和内皮糖蛋白/ Smad1信号通路在纤维化过程中的作用。越来越多的证据表明,TGF-β信号通路下游成分存在疾病特异性改变,这可能为未来的治疗干预提供探索方向。